1 / 17

National Chemotherapy Advisory Group - an update

National Chemotherapy Advisory Group - an update . Elaine Lennan Consultant Nurse. NCAG. History Established 2004 and Co chaired by Professor Mike Richards & Dr Peter Clark Representation from all disciplines Medical, Clinical Oncology and Haematology Paediatrics

hea
Download Presentation

National Chemotherapy Advisory Group - an update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. National Chemotherapy Advisory Group - an update Elaine Lennan Consultant Nurse

  2. NCAG • History • Established 2004 and Co chaired by Professor Mike Richards & Dr Peter Clark • Representation from all disciplines • Medical, Clinical Oncology and Haematology • Paediatrics • Network and PCT Colleagues • Learned lessons from NRAG • Aim To provide advice to the National Cancer Director on: • Safe & Effective Service Delivery • Equity of access to treatments • Commissioning Guidance

  3. Cancer Reform Strategy • Chapter 4 of the Cancer Reform Strategy (Dec 07)covered areas around Chemotherapy: • Drug treatments • NICE Appraisals • Reduced Variation in drug usage • Better local Planning • NCAG • Ensuring safe Delivery of Chemotherapy (Peer review)

  4. Linked very closely to • Darzi review • NRAG • NPSA oral chemo • NCEPOD SACT • Electronic prescribing • Updated national guidance on IT chemotherapy

  5. NCAG would Cover: • Capacity and demand – year on year increases • Potential new service models • Out of hours management • Governance Structures • Workforce requirements • Specific safety issues • The management of febrile neutropenia • Guidance for Commissioners

  6. 4 main sections • 1. Deliver safe and effective care • 2. High Quality Information • 3. Access to new treatments • 4. Commissioning

  7. 1.Deliver safe and effective careService Models • Service Models are currently based on historical arrangements • May focus more on nurse led services • Delivering chemotherapy in different settings • Levels of care • Patient friendly services • Workforce implications • Governance structures to ensure safe services

  8. 1.Deliver safe and effective care Febrile neutropenia • Service guidance not detail of which antibiotic • Minimum safe practice • Timeframes -fever to antibiotic • Advice to patients

  9. 1.Deliver safe and effective care 24 hour emergency care OOH • Equitable access for everyone • ?network based • Staffed by chemo nurses on rota basis • Electronic records • Linked to e prescribing • Local Triage

  10. 2. High quality information • Good quality information lacking • Minimum data set • Horizon scanning • CPORT • E prescribing • Workforce planning

  11. 3.Access to new drugs • Horizon scanning advice • Linked to NICE changes • Informed by 3rd review of NICE uptake

  12. 4. Commissioning • Toolkit - guidance for commissioners • Framework • What facilities – different levels • What policies • What hours etc • ? Clinical pathways

  13. Implications for nurses • First real driver for system change • Work streams led by nurses • Extension of nurse led services • More collaborative work within networks

  14. Next steps post NCAG • Services will need to respond locally probably led by network • Existing work streams may need to develop further work • Interested in being involved? - speak to Network nurse director

  15. NCAG • Possible Publication date October

More Related